Profiel
Jacob J.
Clement joined MIGENIX, Inc. in August 2002.
He is Chief Science Officer and Senior Vice President-Science and Technology for MIGENIX.
Previously, he held various executive and senior management positions with Abbott Laboratories, Scriptgen Pharmaceuticals and Essential Therapeutics.
Dr. Clement received a PhD and a MSPH from the University of North Carolina, an MS degree from Roosevelt University and a BA degree from St. Mary's University.
Eerdere bekende functies van Jacob J. Clement
| Bedrijven | Functie | Einde |
|---|---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Hoofd Techniek/Wetenschap/O&O | 31-01-2009 |
Opleiding van Jacob J. Clement
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Roosevelt University
Roosevelt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saint Mary's University
Saint Mary's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















